SIRT6 and cancer: Moreover, SIRT6’s involvement in cancer cell lineage plasticity, particularly in the context of neuroendocrine differentiation, represents another dimension of its regulatory capabilities, with a study identifying the G protein-coupled receptor, ADORA2A, as a key driver of lineage plasticity through SIRT6-mediated deacetylation processes [167].